dyspepsia
DYSPEPSIA

Dyspepsia is having any one of the following: Disturbing postprandial fullness, early satiation, epigastric pain and/or burning felt predominantly in the upper abdomen.

It is considered a symptom complex rather than a specific diagnosis.

Acid suppression is the recommended initial therapy.

Dyspepsia Patient Education

Patient Education

  • There is no clear evidence of specific association between lifestyle factors and dyspepsia, but some individuals may be helped by these measures
  • To reduce anxiety in cases where there are no indications of organic disease, reassurance is an important part of initial therapy
  • Provide patients with access to educational materials to support the care they receive and emphasize adherence to medical therapy

Lifestyle Modification

  • Advise patients to avoid known precipitants that they associate with dyspeptic symptoms eg alcohol, coffee, chocolate and fatty foods
    • Alcohol, coffee, and chocolate have pharmacological effects that may reduce the tone of the lower esophageal sphincter (LES)
    • Fatty foods delay gastric emptying time which may also predispose to GERD
  • Encourage patient to stop smoking
    • Smoking has pharmacological effects that may reduce the tone of the LES
  • Weight reduction for overweight and obese patients
    • Obesity may disrupt the LES due to mechanical pressure on the diaphragm
  • May suggest having a main meal well before going to bed (preferably 3 hours before)
  • Some patients may benefit from raising the head when sleeping
    • Lying flat may increase reflux episodes since gravity does not prevent acid regurgitation

Other Considerations

  • If there is concurrent use of NSAIDs, evaluate for risk of GI complications and consider alternative strategies if risk is a concern, eg use of enteric-coated NSAIDs 
    • See Peptic Ulcer Disease Disease Management Chart for details
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, 4 days ago
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.